Skip to main content

Aarti Pharmalabs Ltd

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. More about the company

₹873.7
+1.14% today
₹7,922 Cr · Mid cap
Market Neutral — FadingHealth Care 40.6% in Stage 2-7.4 pts / 20dLabs & Life Sciences Services 16.7%-16.7 pts

Pro read

Pro

Our read

Not enough history to read yet

Setup score

—

Momentum

Steady

Edge

—

Is AARTIPHARM early, or has it already run? Pro answers that for every NSE stock, after every close.

Loading price chart…
vs 52W High
—
Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.
Stage Maturity
Week 28
1w13w26w
Week 28 — mature, watch for distribution
How long this stock has been basing. Longer bases can produce stronger breakouts — but don't anticipate, wait for the breakout.
vs 200 DMA
—
—
Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.
Rel Volume
0.30x
vs 50-day avg
Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.
Trend Health
↑
MA20 trending up · +3.5% vs MA50 +11.1%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
+7.5%
3M
+23.4%
6M
+24.8%
YTD
—
1Y
—
Sector
Health Care
↓ Peaking
Stage 2%
40.6%
20d Δ
-7.4pp
1M return
-3.8%
3M return
-1.0%
Sector Stage-2 % · last 20 days
Sector has 67 Stage 2 leaders. See Health Care Stage 2 →
Industry
Labs & Life Sciences Services
↓ Peaking
Stage 2%
16.7%
20d Δ
-16.7pp
1M return
+0.0%
3M return
+23.4%
Industry Stage-2 % · last 20 days
Industry has 1 Stage 2 leader. See Labs & Life Sciences Services Stage 2 →
Stage Cycle Timeline2026-04-02 → 2026-10-16
S? 28w
2026-04-022026-10-16
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 28w current
Total tracked: 28 weeks across 1 stage run.
Scan Membership
Not in any current scan.
Recent Stage Timeline
2026-10-16S—
Wk 28 · Vol 0.30x
2026-10-15S—
Wk 28 · Vol 0.20x
2026-10-14S—
Wk 28 · Vol 0.60x
2026-10-13S—
Wk 27 · Vol 0.50x
2026-10-12S—
Wk 27 · Vol 0.44x
2026-10-09S—
Wk 27 · Vol 0.45x
2026-10-08S—
Wk 27 · Vol 1.18x
2026-10-07S—
Wk 27 · Vol 0.55x
2026-10-06S—
Wk 26 · Vol 0.57x
2026-10-05S—
Wk 26 · Vol 0.67x
2026-10-01S—
Wk 26 · Vol 0.71x
2026-09-30S—
Wk 26 · Vol 1.04x
Sector Peers — Stage 2All →
BAFNAPH
wk 19 · 0.0% from hi
8.6
KILITCH
wk 3 · -11.6% from hi
8.4
LAURUSLABS
wk 26 · -0.4% from hi
7.8
KOPRAN
wk 20 · -6.8% from hi
7.4
ZIMLAB
wk 23 · -5.2% from hi
6.9
Moving averages & range
50 DMA
₹863.6
200 DMA
—
52W High
—
52W Low
—
5D Low
₹863.8
Resistance levels (recent highs)
20d High
₹975
60d High
₹975
120d High
₹975
250d High
—
Next resistance
+11.6%
to 20d High
P/E (TTM)
34.1
Forward —
Earnings Growth (YoY)
-30.8%
Revenue +4.8%
ROE
+8.5%
Profit margin +9.6%
Dividend Yield
0.58%
P/B 2.8
About this companyHealth Care· Labs & Life Sciences Services

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates; xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acid and allied products, including sulphuric acid, sulphur trioxide, oil, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is headquartered in Mumbai, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.